IBDEI07Y ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10422,2)
 ;;=^274721
 ;;^UTILITY(U,$J,358.3,10423,0)
 ;;=854.12^^64^624^113
 ;;^UTILITY(U,$J,358.3,10423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10423,1,3,0)
 ;;=3^TBI-Closed Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,10423,1,4,0)
 ;;=4^854.12
 ;;^UTILITY(U,$J,358.3,10423,2)
 ;;=^274722
 ;;^UTILITY(U,$J,358.3,10424,0)
 ;;=854.13^^64^624^115
 ;;^UTILITY(U,$J,358.3,10424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10424,1,3,0)
 ;;=3^TBI-Closed,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,10424,1,4,0)
 ;;=4^854.13
 ;;^UTILITY(U,$J,358.3,10424,2)
 ;;=^274723
 ;;^UTILITY(U,$J,358.3,10425,0)
 ;;=854.14^^64^624^116
 ;;^UTILITY(U,$J,358.3,10425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10425,1,3,0)
 ;;=3^TBI-Closed,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,10425,1,4,0)
 ;;=4^854.14
 ;;^UTILITY(U,$J,358.3,10425,2)
 ;;=^274724
 ;;^UTILITY(U,$J,358.3,10426,0)
 ;;=908.3^^64^624^17
 ;;^UTILITY(U,$J,358.3,10426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10426,1,3,0)
 ;;=3^Carotid Cavernous Fistula,Late Effect
 ;;^UTILITY(U,$J,358.3,10426,1,4,0)
 ;;=4^908.3
 ;;^UTILITY(U,$J,358.3,10426,2)
 ;;=^275249
 ;;^UTILITY(U,$J,358.3,10427,0)
 ;;=368.2^^64^625^24
 ;;^UTILITY(U,$J,358.3,10427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10427,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,10427,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,10427,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,10428,0)
 ;;=695.3^^64^625^2
 ;;^UTILITY(U,$J,358.3,10428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10428,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,10428,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,10428,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,10429,0)
 ;;=250.00^^64^625^22
 ;;^UTILITY(U,$J,358.3,10429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10429,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,10429,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,10429,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,10430,0)
 ;;=346.90^^64^625^41
 ;;^UTILITY(U,$J,358.3,10430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10430,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,10430,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,10430,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,10431,0)
 ;;=376.30^^64^625^30
 ;;^UTILITY(U,$J,358.3,10431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10431,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,10431,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,10431,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,10432,0)
 ;;=368.8^^64^625^7
 ;;^UTILITY(U,$J,358.3,10432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10432,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,10432,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,10432,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,10433,0)
 ;;=362.34^^64^625^5
 ;;^UTILITY(U,$J,358.3,10433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10433,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,10433,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,10433,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,10434,0)
 ;;=368.13^^64^625^87
 ;;^UTILITY(U,$J,358.3,10434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10434,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,10434,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,10434,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,10435,0)
 ;;=368.40^^64^625^112
 ;;^UTILITY(U,$J,358.3,10435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10435,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,10435,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,10435,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,10436,0)
 ;;=369.4^^64^625^58
 ;;^UTILITY(U,$J,358.3,10436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10436,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,10436,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,10436,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,10437,0)
 ;;=250.01^^64^625^21
 ;;^UTILITY(U,$J,358.3,10437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10437,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,10437,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10437,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,10438,0)
 ;;=V08.^^64^625^40
 ;;^UTILITY(U,$J,358.3,10438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10438,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,10438,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,10438,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,10439,0)
 ;;=921.0^^64^625^16
 ;;^UTILITY(U,$J,358.3,10439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10439,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,10439,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,10439,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,10440,0)
 ;;=379.91^^64^625^86
 ;;^UTILITY(U,$J,358.3,10440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10440,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,10440,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,10440,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,10441,0)
 ;;=V58.69^^64^625^44
 ;;^UTILITY(U,$J,358.3,10441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10441,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,10441,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,10441,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,10442,0)
 ;;=871.4^^64^625^54
 ;;^UTILITY(U,$J,358.3,10442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10442,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,10442,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,10442,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,10443,0)
 ;;=242.90^^64^625^107
 ;;^UTILITY(U,$J,358.3,10443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10443,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,10443,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,10443,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,10444,0)
 ;;=135.^^64^625^100
 ;;^UTILITY(U,$J,358.3,10444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10444,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,10444,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,10444,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,10445,0)
 ;;=446.5^^64^625^106
 ;;^UTILITY(U,$J,358.3,10445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10445,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,10445,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,10445,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,10446,0)
 ;;=401.9^^64^625^49
 ;;^UTILITY(U,$J,358.3,10446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10446,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,10446,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,10446,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,10447,0)
 ;;=V72.0^^64^625^32
 ;;^UTILITY(U,$J,358.3,10447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10447,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,10447,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,10447,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,10448,0)
 ;;=V41.0^^64^625^90
 ;;^UTILITY(U,$J,358.3,10448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10448,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,10448,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,10448,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,10449,0)
 ;;=998.59^^64^625^88
 ;;^UTILITY(U,$J,358.3,10449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10449,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,10449,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,10449,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,10450,0)
 ;;=042.^^64^625^1
 ;;^UTILITY(U,$J,358.3,10450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10450,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,10450,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,10450,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,10451,0)
 ;;=053.29^^64^625^43
 ;;^UTILITY(U,$J,358.3,10451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10451,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,10451,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,10451,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,10452,0)
 ;;=054.40^^64^625^42
 ;;^UTILITY(U,$J,358.3,10452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10452,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,10452,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,10452,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,10453,0)
 ;;=190.1^^64^625^82
 ;;^UTILITY(U,$J,358.3,10453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10453,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10453,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,10453,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,10454,0)
 ;;=190.2^^64^625^50
 ;;^UTILITY(U,$J,358.3,10454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10454,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10454,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,10454,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,10455,0)
 ;;=190.7^^64^625^52
 ;;^UTILITY(U,$J,358.3,10455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10455,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10455,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,10455,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,10456,0)
 ;;=202.81^^64^625^61
 ;;^UTILITY(U,$J,358.3,10456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10456,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,10456,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,10456,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,10457,0)
 ;;=215.9^^64^625^84
 ;;^UTILITY(U,$J,358.3,10457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10457,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,10457,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,10457,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,10458,0)
 ;;=224.2^^64^625^51
 ;;^UTILITY(U,$J,358.3,10458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10458,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10458,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,10458,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,10459,0)
 ;;=224.5^^64^625^95
 ;;^UTILITY(U,$J,358.3,10459,1,0)
 ;;=^358.31IA^4^2
